Business News • PR NewsWire • Nordic Nanovector - Invitation to Conference Call for Updated Clinical Trial Results Reported at the International Conference on Malignant Lymphoma

Nordic Nanovector - Invitation to Conference Call for Updated Clinical Trial Results Reported at the International Conference on Malignant Lymphoma

Nordic Nanovector - Invitation to Conference Call for Updated Clinical Trial Results Reported at the International Conference on Malignant Lymphoma

OSLO, Norway, 13 June, 2017 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANO) will host a conference call on Wednesday, 14 June at 1 pm CET to present updated results from its ongoing LYMRIT 37-01 Phase 1/2 clinical trial of Betalutin® in patients with relapsed/refractory indolent...

View More : http://www.prnewswire.com/news-releases/nordic-nanovector---invitation-to-conference-call-for-updated-clinical-trial-res...

Releted News by prnewswire

SSH Communications Security Introduces Access Management at the Speed of Cloud

Keisei Bus Takes Initiative to Satisfy Foreigners Visiting Japan: Going Multilingual in Bus Transport Services -- on Board, at Bus Stops and in Attending Customers